サマリー

天然痘治療の世界市場 2022-2026 年
Technavioは天然痘治療市場を監視しており、2022-2026年の間に6610万ドル、予測期間中にCAGR1.76%で加速して成長すると予測しています。当レポートでは、天然痘治療市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。天然痘治療薬の備蓄増加、医薬品認可の増加、製造委託の増加などが市場を牽引しています。
天然痘治療市場の分析には、製品セグメントや地理的状況も含まれます。
Technavioの天然痘治療市場は、以下のように区分されています。
製品別
- 医薬品
- ワクチン
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間の天然痘治療市場の成長を促進する主要な理由の1つとして、ベンダーによる取り組みの増加を挙げています。また、バイオテロの脅威の高まりと迅速な承認が、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細なイメージを提示します。天然痘治療市場に関する当レポートは、以下の分野を対象としています。
- 天然痘治療市場のサイジング
- 天然痘治療市場の予測
- 天然痘治療市場の産業分析
Technavioの堅牢なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Bavarian Nordic AS、Chimerix Inc、Emergent BioSolutions Inc、EpiVax Inc、Gilead Sciences Inc.、KM Biologics Co.Ltd.、Marker Therapeutics Inc.、Nano Therapeutics Pvt. Ltd.、Oncovir Inc.、Pfizer Inc.、Symphogen、Tonix Pharmaceuticals Holding、SIGA Technologies Inc.、Cel Sci Corp.の各社が含まれています。また、天然痘治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/smallpox-treatment-market-size-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Drugs - Market size and forecast 2021-2026
o Exhibit 28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
o 5.4 Vaccines - Market size and forecast 2021-2026
o Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 India - Market size and forecast 2021-2026
o Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Bavarian Nordic AS
o Exhibit 89: Bavarian Nordic AS - Overview
o Exhibit 90: Bavarian Nordic AS - Product / Service
o Exhibit 91: Bavarian Nordic AS - Key news
o Exhibit 92: Bavarian Nordic AS - Key offerings
o 10.4 Cel Sci Corp.
o Exhibit 93: Cel Sci Corp. - Overview
o Exhibit 94: Cel Sci Corp. - Product / Service
o Exhibit 95: Cel Sci Corp. - Key offerings
o 10.5 Chimerix Inc.
o Exhibit 96: Chimerix Inc. - Overview
o Exhibit 97: Chimerix Inc. - Product / Service
o Exhibit 98: Chimerix Inc. - Key offerings
o 10.6 Emergent BioSolutions Inc.
o Exhibit 99: Emergent BioSolutions Inc. - Overview
o Exhibit 100: Emergent BioSolutions Inc. - Product / Service
o Exhibit 101: Emergent BioSolutions Inc. - Key news
o Exhibit 102: Emergent BioSolutions Inc. - Key offerings
o 10.7 EpiVax Inc.
o Exhibit 103: EpiVax Inc. - Overview
o Exhibit 104: EpiVax Inc. - Product / Service
o Exhibit 105: EpiVax Inc. - Key offerings
o 10.8 Gilead Sciences Inc.
o Exhibit 106: Gilead Sciences Inc. - Overview
o Exhibit 107: Gilead Sciences Inc. - Product / Service
o Exhibit 108: Gilead Sciences Inc. - Key news
o Exhibit 109: Gilead Sciences Inc. - Key offerings
o 10.9 KM Biologics Co. Ltd.
o Exhibit 110: KM Biologics Co. Ltd. - Overview
o Exhibit 111: KM Biologics Co. Ltd. - Product / Service
o Exhibit 112: KM Biologics Co. Ltd. - Key offerings
o 10.10 Nano Therapeutics Pvt. Ltd.
o Exhibit 113: Nano Therapeutics Pvt. Ltd. - Overview
o Exhibit 114: Nano Therapeutics Pvt. Ltd. - Key offerings
o 10.11 Pfizer Inc.
o Exhibit 115: Pfizer Inc. - Overview
o Exhibit 116: Pfizer Inc. - Product / Service
o Exhibit 117: Pfizer Inc. - Key news
o Exhibit 118: Pfizer Inc. - Key offerings
o 10.12 SIGA Technologies Inc.
o Exhibit 119: SIGA Technologies Inc. - Overview
o Exhibit 120: SIGA Technologies Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 121: Inclusions checklist
o Exhibit 122: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 123: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 124: Research methodology
o Exhibit 125: Validation techniques employed for market sizing
o Exhibit 126: Information sources
o 11.5 List of abbreviations
o Exhibit 127: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Bavarian Nordic AS - Overview
Exhibits90: Bavarian Nordic AS - Product / Service
Exhibits91: Bavarian Nordic AS - Key news
Exhibits92: Bavarian Nordic AS - Key offerings
Exhibits93: Cel Sci Corp. - Overview
Exhibits94: Cel Sci Corp. - Product / Service
Exhibits95: Cel Sci Corp. - Key offerings
Exhibits96: Chimerix Inc. - Overview
Exhibits97: Chimerix Inc. - Product / Service
Exhibits98: Chimerix Inc. - Key offerings
Exhibits99: Emergent BioSolutions Inc. - Overview
Exhibits100: Emergent BioSolutions Inc. - Product / Service
Exhibits101: Emergent BioSolutions Inc. - Key news
Exhibits102: Emergent BioSolutions Inc. - Key offerings
Exhibits103: EpiVax Inc. - Overview
Exhibits104: EpiVax Inc. - Product / Service
Exhibits105: EpiVax Inc. - Key offerings
Exhibits106: Gilead Sciences Inc. - Overview
Exhibits107: Gilead Sciences Inc. - Product / Service
Exhibits108: Gilead Sciences Inc. - Key news
Exhibits109: Gilead Sciences Inc. - Key offerings
Exhibits110: KM Biologics Co. Ltd. - Overview
Exhibits111: KM Biologics Co. Ltd. - Product / Service
Exhibits112: KM Biologics Co. Ltd. - Key offerings
Exhibits113: Nano Therapeutics Pvt. Ltd. - Overview
Exhibits114: Nano Therapeutics Pvt. Ltd. - Key offerings
Exhibits115: Pfizer Inc. - Overview
Exhibits116: Pfizer Inc. - Product / Service
Exhibits117: Pfizer Inc. - Key news
Exhibits118: Pfizer Inc. - Key offerings
Exhibits119: SIGA Technologies Inc. - Overview
Exhibits120: SIGA Technologies Inc. - Key offerings
Exhibits121: Inclusions checklist
Exhibits122: Exclusions checklist
Exhibits123: Currency conversion rates for US$
Exhibits124: Research methodology
Exhibits125: Validation techniques employed for market sizing
Exhibits126: Information sources
Exhibits127: List of abbreviations